omegakimia@yahoo.com
Posted in KPJ Johor

复杂血管成形术治疗重度钙化动脉:斑块旋切术和IVL解释

Complex angioplasty Coronary complex angioplasty has transformed the treatment of coronary artery disease. For many patients, a narrowed coronary artery can be treated safely with a balloon and coronary stent. However, not every coronary blockage is straightforward. Some patients have severely narrowed arteries with extensive calcium deposits. These are known as heavily calcified coronary lesions, […]

来自Johor Bahru Lim医生的心血管风险必需的LDL-C降低
omegakimia@yahoo.com
Posted in Drug Talk

来自Johor Bahru Lim医生的心血管风险必需的LDL-C降低

Dr Lim Wei Juan Advancing Cardiovascular, Renal and Metabolic Care On 15 August 2026, I was honored to be invited as a speaker alongside dr lim wei juan. The event Pharmacy in Motion: Empowering Access, Adherence, Outcomes, was held at Amari Hotel in Johor Bahru. This healthcare professional meeting focused on cardiovascular, renal and metabolic […]

糖尿病护理研讨会 – 南部:推进糖尿病中的心脏代谢风险管理
omegakimia@yahoo.com
Posted in Drug Talk

糖尿病护理研讨会 – 南部:推进糖尿病中的心脏代谢风险管理

On 1 August 2026, I was honoured to be invited as a speaker at the Diabetes Care Workshop – Southern, held at St Giles Hotel, Johor Bahru. The workshop brought together healthcare professionals, including approximately 50 general practitioners, with the aim of enhancing practical and comprehensive diabetes management. Organised with the support of the Abbott […]

Heart Health Talk for MMHE Employees | KPJ Johor Specialist Hospital
omegakimia@yahoo.com
Posted in KPJ Johor

Heart Health Talk for MMHE Employees | KPJ Johor Specialist Hospital

On 14 July 2026, Dr Lim Wei Juan, Consultant Cardiologist at KPJ Johor Specialist Hospital, was honoured to conduct a Heart Health Awareness Talk for the employees of Malaysia Marine and Heavy Engineering (MMHE). The educational session was part of MMHE’s ongoing commitment to promoting employee wellness and preventive healthcare. The interactive talk focused on […]

omegakimia@yahoo.com
Posted in Uncategorized

Sybrava (siRNA): The Next Marathon in ASCVD Management

Sybrava For decades, cardiologists have focused on one goal: lowering LDL cholesterol (“bad cholesterol”) to prevent heart attacks and strokes. Yet despite high-intensity statins, ezetimibe, and lifestyle modification, many patients with Atherosclerotic Cardiovascular Disease (ASCVD) still fail to achieve guideline-recommended LDL-C targets. The question is no longer: “Should we lower LDL cholesterol?” The real question […]